Objective:To evaluate the efficacy of DynaCT-assisted DEB-TACE in the treatment of primary liver cancer and its clinical advantages compared to traditional transcatheter arterial chemoembolization(TACE).Methods:Sixty-...Objective:To evaluate the efficacy of DynaCT-assisted DEB-TACE in the treatment of primary liver cancer and its clinical advantages compared to traditional transcatheter arterial chemoembolization(TACE).Methods:Sixty-four patients with primary liver cancer were enrolled as the study subjects.They were randomly divided into two groups according to the number table method.展开更多
Acute-on-chronic liver failure(ACLF)is a distinct condition characterized by the abrupt exacerbation of pre-existing chronic liver disease,often leading to multi-organ failures and significant short-term mortalities.B...Acute-on-chronic liver failure(ACLF)is a distinct condition characterized by the abrupt exacerbation of pre-existing chronic liver disease,often leading to multi-organ failures and significant short-term mortalities.Bacterial infection is one of the most frequent triggers for ACLF and a common complication following its onset.The impact of bacterial infections on the clinical course and outcome of ACLF underscores their critical role in the pathogenesis of systemic inflammation and organ failures.In addition,the evolving epidemiology and increasing prevalence of multidrug-resistant bacteria in cirrhosis and ACLF highlight the importance of appropriate empirical antibiotic use,as well as accurate and prompt microbiological diagnosis.This review provided an update on recent advances in the epidemiology,diagnosis,pathogenesis,and management of bacterial infections in ACLF.展开更多
文摘Objective:To evaluate the efficacy of DynaCT-assisted DEB-TACE in the treatment of primary liver cancer and its clinical advantages compared to traditional transcatheter arterial chemoembolization(TACE).Methods:Sixty-four patients with primary liver cancer were enrolled as the study subjects.They were randomly divided into two groups according to the number table method.
基金supported by the National Key Research and Development Program of China(No.2022YFC2304501 and No.2021YFC2301800)the Fundamental Research Funds for the Central Universities(2023QZJH50)+1 种基金Medical Health Science and Technology Project of Zhejiang Provincial Health Commission(No.2022RC141)the Chinese National Natural Science Foundation(No.81870425).
文摘Acute-on-chronic liver failure(ACLF)is a distinct condition characterized by the abrupt exacerbation of pre-existing chronic liver disease,often leading to multi-organ failures and significant short-term mortalities.Bacterial infection is one of the most frequent triggers for ACLF and a common complication following its onset.The impact of bacterial infections on the clinical course and outcome of ACLF underscores their critical role in the pathogenesis of systemic inflammation and organ failures.In addition,the evolving epidemiology and increasing prevalence of multidrug-resistant bacteria in cirrhosis and ACLF highlight the importance of appropriate empirical antibiotic use,as well as accurate and prompt microbiological diagnosis.This review provided an update on recent advances in the epidemiology,diagnosis,pathogenesis,and management of bacterial infections in ACLF.
